Literature DB >> 11172474

Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus.

A Wajngot1, V Chandramouli, W C Schumann, K Ekberg, P K Jones, S Efendic, B R Landau.   

Abstract

Contributions of gluconeogenesis to glucose production were determined between 14 to 22 hours into a fast in type 2 diabetics (n = 9) and age-weight-matched controls (n = 7); ages, 60.4 +/- 2.3 versus 55.6 +/- 1.2 years and body mass indices (BMI) 28.6 +/- 2.3 versus 26.6 +/- 0.8 kg/m2. Production was measured using a primed-continuous [6,6-2H2]glucose infusion and gluconeogenesis from 2H enrichment at carbons 2 and 5 of blood glucose on 2H2O ingestion. Plasma glucose concentration declined from 9.6 +/- 0.6 at 14 hours to 7.3 +/- 0.6 at 22 hours in the diabetics (P = .001) and from 5.4 +/- 0.1 to 5.0 +/- 0.1 in the controls (P < .05). Production from the 17th to 22nd hour declined 27.1% +/- 0.6% in the diabetics versus 18.5% +/- 0.8% in the controls (P = .001); from 10.4 +/- 0.3 to 7.6 +/- 0.2 versus 10.0 +/- 0.4 to 8.2 +/- 0.4 micromol/kg/min. Percent contributions of gluconeogenesis to production measured at 1 1/2 to 2-hour intervals beginning the 15th hour were 6.8% +/- 1.0% more in the diabetics than controls. The quantity of glucose contributed by gluconeogenesis declined 19.8% +/- 3.8% (P < .001) in the diabetics and 6.9% +/- 2.3% in the controls (P = .05); 7.21 +/- 0.32 to 5.74 +/- 0.26 versus 6.20 +/- 0.28 to 5.75 +/- 0.24 micromol/kg/min. The contribution of glycogenolysis to production, estimated from the difference between production and gluconeogenesis, declined to the same extent in diabetic and control subjects, 40.7% +/- 6.6% and 37.7% +/- 4.1%; from 3.23 +/- 0.35 to 1.86 +/- 0.26 versus 3.81 +/- 0.22 to 2.42 +/- 0.28 micromol/kg/min. Thus, gluconeogenesis contributed more to glucose production in the diabetic than control subjects. Production and the contribution of gluconeogenesis declined more in the diabetic subjects during the fast. The factors regulating these changes remain uncertain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172474     DOI: 10.1053/meta.2001.19422

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  38 in total

Review 1.  Is hepatic glucose production increased in type 2 diabetes mellitus?

Authors:  Henning Beck-Nielsen; Ole Hother-Nielsen; Peter Staehr
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 2.  The role of the liver in type 2 diabetes.

Authors:  Peter Staehr; Ole Hother-Nielsen; Henning Beck-Nielsen
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  Anti-inflammatory and anti-hyperlipidemic effect of Semecarpus anacardium in a high fat diet: STZ-induced type 2 diabetic rat model.

Authors:  Haseena Banu Hedayathullah Khan; Kaladevi Siddhi Vinayagam; Balaji T Moorthy; Shanthi Palanivelu; Sachdanandam Panchanatham
Journal:  Inflammopharmacology       Date:  2012-01-25       Impact factor: 4.473

4.  Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?

Authors:  J Radziuk; S Pye
Journal:  Diabetologia       Date:  2006-05-16       Impact factor: 10.122

5.  Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice.

Authors:  J McKee Alderman; Kevin Flurkey; Natasha L Brooks; Sneha B Naik; Jonathan M Gutierrez; Urmila Srinivas; Kristen B Ziara; Linhong Jing; Gunnar Boysen; Rod Bronson; Simon Klebanov; Xian Chen; James A Swenberg; Mats Stridsberg; Carol E Parker; David E Harrison; Terry P Combs
Journal:  Exp Gerontol       Date:  2008-06-07       Impact factor: 4.032

6.  In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way.

Authors:  Lingzi Li; Juliette Martin-Levilain; Cecilia Jiménez-Sánchez; Melis Karaca; Michelangelo Foti; Jean-Claude Martinou; Pierre Maechler
Journal:  J Biol Chem       Date:  2019-07-08       Impact factor: 5.157

7.  Structure and activity of the metal-independent fructose-1,6-bisphosphatase YK23 from Saccharomyces cerevisiae.

Authors:  Ekaterina Kuznetsova; Linda Xu; Alexander Singer; Greg Brown; Aiping Dong; Robert Flick; Hong Cui; Marianne Cuff; Andrzej Joachimiak; Alexei Savchenko; Alexander F Yakunin
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

8.  The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.

Authors:  A A Yarushkin; E M Kachaylo; V O Pustylnyak
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 9.  Current understanding of metformin effect on the control of hyperglycemia in diabetes.

Authors:  Hongying An; Ling He
Journal:  J Endocrinol       Date:  2016-01-07       Impact factor: 4.286

10.  PEPCK1 Antisense Oligonucleotide Prevents Adiposity and Impairs Hepatic Glycogen Synthesis in High-Fat Male Fed Rats.

Authors:  Sara A Beddow; Arijeet K Gattu; Daniel F Vatner; Lauren Paolella; Abdulelah Alqarzaee; Nedda Tashkandi; Violeta B Popov; Christopher D Church; Matthew S Rodeheffer; Gary W Cline; John G Geisler; Sanjay Bhanot; Varman T Samuel
Journal:  Endocrinology       Date:  2019-01-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.